{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:53:29Z","timestamp":1790952809261,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jaad.2017.09.053","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T15:45:27Z","timestamp":1507650327000},"page":"363-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma"],"prefix":"10.1016","volume":"78","author":[{"given":"Eunice","family":"Del Rosario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Florez-Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Lucio","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tovar-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Hynan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2017.09.053_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2010.12.046","article-title":"Melasma: a comprehensive update: part I","volume":"65","author":"Sheth","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.09.053_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/archderm.143.3.424","article-title":"Prevalence of self-diagnosed melasma among premenopausal Latino women in\u00a0Dallas and Fort Worth, Tex","volume":"143","author":"Werlinger","year":"2007","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.09.053_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdermsci.2007.01.009","article-title":"The vascular characteristics of melasma","volume":"46","author":"Kim","year":"2007","journal-title":"J Dermatol Sci"},{"issue":"9","key":"10.1016\/j.jaad.2017.09.053_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jama.1967.03120090043007","article-title":"Melasma induced by oral contraceptive drugs","volume":"199","author":"Resnik","year":"1967","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jaad.2017.09.053_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/jid.1962.136","article-title":"Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light","volume":"39","author":"Pathak","year":"1962","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.09.053_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jocd.12026","article-title":"Tranexamic acid: an important adjuvant in the treatment of melasma","volume":"12","author":"Tse","year":"2013","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.09.053_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","article-title":"Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis","volume":"75","author":"Lee","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.09.053_bib8","first-page":"1051","article-title":"Interpretability of the modified melasma area and severity index (mMASI)","volume":"152","author":"Rodrigues","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jaad.2017.09.053_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2133.2003.05419.x","article-title":"Development and validation of a health-related quality of life instrument for\u00a0women with melasma","volume":"149","author":"Balkrishnan","year":"2003","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.09.053_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2006.01.049","article-title":"Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language","volume":"55","author":"Dominguez","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.053_bib11","unstructured":"Hintze, J. 2013. PASS 12. NCSS, LLC. Kaysville, Utah, USA. Available at: www.ncss.com. Accessed November 6, 2017."},{"issue":"3","key":"10.1016\/j.jaad.2017.09.053_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.det.2007.04.006","article-title":"Therapeutical approaches in melasma","volume":"25","author":"Prignano","year":"2007","journal-title":"Dermatol Clin"},{"issue":"6","key":"10.1016\/j.jaad.2017.09.053_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials","volume":"55","author":"Gupta","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.09.053_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/jidsymp.2008.7","article-title":"Latest insights into skin hyperpigmentation","volume":"13","author":"Ortonne","year":"2008","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"10.1016\/j.jaad.2017.09.053_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0007-0963.2001.04556.x","article-title":"Melasma: histopathological characteristics in 56 Korean patients","volume":"146","author":"Kang","year":"2002","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.09.053_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2230.2008.02724.x","article-title":"Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma","volume":"33","author":"Hern\u00e1ndez-Barrera","year":"2008","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.09.053_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/DAD.0b013e3181ef2d45","article-title":"Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane","volume":"33","author":"Torrez-\u00c1lvarez","year":"2011","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.jaad.2017.09.053_bib18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-2133.2006.07179.x","article-title":"The dermal stem cell factor and c-kit are overexpressed in melasma","volume":"154","author":"Kang","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.053_bib19","first-page":"3129","article-title":"Treatment of melasma with tranexamic acid","volume":"13","author":"Nijor","year":"1979","journal-title":"Clin Res"},{"issue":"8","key":"10.1016\/j.jaad.2017.09.053_bib20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-3083.2012.04464.x","article-title":"Effect of tranexamic acid on melasma: a clinical trial with histological evaluation","volume":"27","author":"Na","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2017.09.053_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1248\/jhs.53.389","article-title":"Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium","volume":"53","author":"Maeda","year":"2007","journal-title":"J Health Sci"},{"issue":"5","key":"10.1016\/j.jaad.2017.09.053_bib22","first-page":"626","article-title":"Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial","volume":"32","author":"Lee","year":"2006","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.jaad.2017.09.053_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/ced.12835","article-title":"Efficacy and possible mechanisms of topical tranexamic acid in melasma","volume":"41","author":"Kim","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.09.053_bib24","series-title":"Lysteda [package insert]","year":"2011"},{"key":"10.1016\/j.jaad.2017.09.053_bib25","first-page":"412","article-title":"Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety","volume":"4","author":"Leminen","year":"2012","journal-title":"Int J Womens Health"},{"issue":"2","key":"10.1016\/j.jaad.2017.09.053_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jocd.12291","author":"Lajevardi","year":"2017","journal-title":"J Cosmet Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217324581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217324581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:45:30Z","timestamp":1759272330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217324581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0190962217324581"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.09.053","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731932316.793592682","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.09.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}